Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127117502 | 12711750 | 2 | F | 20160810 | 20160909 | 20160902 | 20160913 | EXP | IT-ROCHE-1824298 | ROCHE | 56.16 | YR | M | Y | 0.00000 | 20160913 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127117502 | 12711750 | 1 | PS | XENICAL | ORLISTAT | 1 | Oral | HARD CAPSULE | Y | 20766 | 240 | MG | CAPSULE | QD | |||||
| 127117502 | 12711750 | 2 | I | COUMADIN | WARFARIN SODIUM | 1 | Oral | Y | 0 | 5 | MG | QD | |||||||
| 127117502 | 12711750 | 3 | I | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | Y | 0 | 150 | MG | QD | |||||||
| 127117502 | 12711750 | 4 | C | RIBOFLAVIN SODIUM PHOSPHATE | 2 | Unknown | PERIOD OF ADMINISTRATION:7 MONTHS | 0 | 400 | MG | |||||||||
| 127117502 | 12711750 | 5 | C | NICOTINAMIDE | NIACINAMIDE | 1 | Unknown | PERIOD OF ADMINISTRATION:2 YEARS | 0 | 2 | DF | ||||||||
| 127117502 | 12711750 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | PERIOD OF ADMINISTRATION:7 YEARS | 0 | 60 | MG | ||||||||
| 127117502 | 12711750 | 7 | C | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | PERIOD OF ADMINISTRATION:9 MONTHS | 0 | 1.8 | MG | ||||||||
| 127117502 | 12711750 | 8 | C | COAPROVEL | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | Oral | 25 MG TAB ; PERIOD OF ADMINISTRATION:7 MONTHS | 0 | 300 | MG | ||||||||
| 127117502 | 12711750 | 9 | C | TACHIPIRINA | ACETAMINOPHEN | 1 | Unknown | PERIOD OF ADMINISTRATION:9 MONTHS | 0 | 3 | G | ||||||||
| 127117502 | 12711750 | 10 | C | CARNITENE | 2 | Unknown | PERIOD OF ADMINISTRATION:3 YEARS | 0 | 4 | G | |||||||||
| 127117502 | 12711750 | 11 | C | XATRAL | ALFUZOSIN | 1 | Unknown | PERIOD OF ADMINISTRATION:7 YEARS | 0 | 10 | MG | ||||||||
| 127117502 | 12711750 | 12 | C | CIALIS | TADALAFIL | 1 | Unknown | PERIOD OF ADMINISTRATION:3 YEARS | 0 | 5 | MG | ||||||||
| 127117502 | 12711750 | 13 | C | EVION | .ALPHA.-TOCOPHEROL ACETATE | 1 | Unknown | PERIOD OF ADMINISTRATION:7 YEARS | 0 | 100 | MG | ||||||||
| 127117502 | 12711750 | 14 | C | ZYLORIC | ALLOPURINOL | 1 | Unknown | PERIOD OF ADMINISTRATION:6 YEARS | 0 | 300 | MG | ||||||||
| 127117502 | 12711750 | 15 | C | LYRICA | PREGABALIN | 1 | Unknown | PERIOD OF ADMINISTRATION:4 YEARS | 0 | 450 | MG | ||||||||
| 127117502 | 12711750 | 16 | C | EN | DELORAZEPAM | 1 | Unknown | PERIOD OF ADMINISTRATION:6 MONTHS | 0 | 2 | MG | ||||||||
| 127117502 | 12711750 | 17 | C | LARGACTIL | CHLORPROMAZINE | 1 | Unknown | PERIOD OF ADMINISTRATION:6 MONTHS | 0 | 50 | MG | ||||||||
| 127117502 | 12711750 | 18 | C | PREFOLIC | LEUCOVORIN CALCIUM | 1 | Unknown | PERIOD OF ADMINISTRATION:7 YEARS | 0 | 15 | MG | ||||||||
| 127117502 | 12711750 | 19 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | PERIOD OF ADMINISTRATION:6 MONTHS | 0 | 30 | MG | ||||||||
| 127117502 | 12711750 | 20 | C | ABSORCOL | 2 | Unknown | PERIOD OF ADMINISTRATION:7 YEARS | 0 | 10 | MG | |||||||||
| 127117502 | 12711750 | 21 | C | ESAPENT | 2 | Oral | PERIOD OF ADMINISTRATION:6 YEARS | 0 | 2 | G | |||||||||
| 127117502 | 12711750 | 22 | C | LASIX | FUROSEMIDE | 1 | Oral | PERIOD OF ADMINISTRATION:8 YEARS | 0 | 25 | MG | ||||||||
| 127117502 | 12711750 | 23 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | PERIOD OF ADMINISTRATION:6 MONTHS | 0 | 10 | MG | ||||||||
| 127117502 | 12711750 | 24 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | PERIOD OF ADMINISTRATION:3 YEARS | 0 | 60 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127117502 | 12711750 | 1 | Obesity |
| 127117502 | 12711750 | 2 | Thrombosis prophylaxis |
| 127117502 | 12711750 | 3 | Depression |
| 127117502 | 12711750 | 7 | Diabetes mellitus |
| 127117502 | 12711750 | 8 | Hypertension |
| 127117502 | 12711750 | 16 | Phobia |
| 127117502 | 12711750 | 17 | Phobia |
| 127117502 | 12711750 | 24 | Phobia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127117502 | 12711750 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127117502 | 12711750 | Drug interaction | |
| 127117502 | 12711750 | International normalised ratio increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127117502 | 12711750 | 1 | 20160401 | 20160816 | 0 | |
| 127117502 | 12711750 | 2 | 20090101 | 0 | ||
| 127117502 | 12711750 | 3 | 20160501 | 20160816 | 0 |